Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Schizophrenia Episode”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT03055338
What this trial is testing

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

Who this might be right for
Schizophrenia, Acute Episode
Merck Sharp & Dohme LLC 224
Testing effectiveness (Phase 2)Study completedNCT04624243
What this trial is testing

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 499
Post-approval studies (Phase 4)UnknownNCT00157378
What this trial is testing

Optimization of Acute Treatment in First Episode Schizophrenia

Who this might be right for
Schizophrenia, First-Episode
Ludwig-Maximilians - University of Munich 300
Large-scale testing (Phase 3)Study completedNCT00240721
What this trial is testing

The Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder

Who this might be right for
Bipolar DisordersMood DisordersAffective Disorders, Psychotic
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 363
Large-scale testing (Phase 3)Study completedNCT00299715
What this trial is testing

Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-release Paliperidone in Subjects With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Large-scale testing (Phase 3)Study completedNCT00882518
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate in the Treatment of Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 388
Not applicableStudy completedNCT03235908
What this trial is testing

Copeptin in Outcome Prediction of an Acute Psychotic Episode

Who this might be right for
Acute Psychotic EpisodeSchizophrenia Spectrum and Other Psychotic DisordersAffective Disorder+1 more
University Hospital, Basel, Switzerland 73
Large-scale testing (Phase 3)Study completedNCT00309686
What this trial is testing

Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder

Who this might be right for
Affective Psychosis, BipolarBipolar DisorderMania
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 300
Post-approval studies (Phase 4)Study completedNCT00216671
What this trial is testing

Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 220
Not applicableActive Not RecruitingNCT04916626
What this trial is testing

The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+5 more
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 284
Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing

Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493
Large-scale testing (Phase 3)UnknownNCT05168007
What this trial is testing

Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Whanin Pharmaceutical Company 342
Not applicableUnknownNCT06007105
What this trial is testing

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizotypal Disorder+8 more
London School of Hygiene and Tropical Medicine 40
Post-approval studies (Phase 4)Study completedNCT03289026
What this trial is testing

Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study

Who this might be right for
Acute Schizophrenia Episode
Peking University 770
Not applicableStudy completedNCT01491412
What this trial is testing

Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia

Who this might be right for
Acute Psychotic EpisodeSchizophrenia
AstraZeneca 503
Large-scale testing (Phase 3)Study completedNCT01541371
What this trial is testing

Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia

Who this might be right for
Schizophrenia
Xian-Janssen Pharmaceutical Ltd. 405
Not applicableLooking for participantsNCT06687694
What this trial is testing

Immune Mechanisms of Antipsychotic Treatment Response

Who this might be right for
Psychosis
King's College London 500
Not applicableStudy completedNCT00631722
What this trial is testing

Multicenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of Schizophrenia

Who this might be right for
Schizophrenia
Peking University 80
Not applicableStudy completedNCT01544608
What this trial is testing

Observe Real-life Allocation of Atypical Antipsychotics in the Acute Inpatient Management of Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 1,076
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Load More Results